Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
2019
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 Standout
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
2016
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management
2017
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
What is polypharmacy? A systematic review of definitions
2017 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
2017 Standout
Cost-Effectiveness of Split-Night Polysomnography and Home Studies in the Evaluation of Obstructive Sleep Apnea Syndrome
2006
A new taxonomy for describing and defining adherence to medications
2012 Standout
Osteoporosis
2019 Standout
A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care
2011
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Análisis coste-efectividad del cribado universal de la enfermedad tiroidea en mujeres embarazadas en España
2015
From non-A, non-B hepatitis to hepatitis C virus cure
2015
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
2012
Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea
2006
The future cost of stroke in Ireland: an analysis of the potential impact of demographic change and implementation of evidence-based therapies
2013
Burden of liver diseases in the world
2018 Standout
Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
2012 Standout
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
2019 Standout
High density associated enzymes: their role in vascular biology
1998
An essential role for Rxrα in the development of Th2 responses
2005 StandoutNobel
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
2012
The Economic Impact of Obstructive Sleep Apnea
2007
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins
2000
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial
2011
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
2012
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
2006
Current and evolving treatment strategies for the Alzheimer disease continuum
2020
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
2012
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 Standout
Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C
2005
Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program
2015
Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5
2012
Inflammation in atherosclerosis
2002 StandoutNature
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
2004 Standout
Cost-Effectiveness of Optimizing Acute Stroke Care Services for Thrombolysis
2014
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
2007
Amyloid biomarkers in Alzheimer's disease
2015
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Medication Adherence: WHO Cares?
2011 Standout
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Prevalence of obstructive sleep apnea in the general population: A systematic review
2016 Standout
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—From evidence-based medicine to the real-life setting
2015
The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension
2003
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic Lesions
2003
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
The influence of absolute cardiovascular risk, patient utilities and costs on the decision to treat hypertension
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Inflammation in Atherosclerosis
2012 Standout
State-Transition Modeling
2012
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review
2019 Standout
Model Transparency and Validation
2012
Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update
2021
An Integrated Health-Economic Analysis of Diagnostic and Therapeutic Strategies in the Treatment of Moderate-to-Severe Obstructive Sleep Apnea
2011
Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography
2000
Model Parameter Estimation and Uncertainty Analysis
2012
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Dynamic Transmission Modeling
2012
Burden of Stroke in Europe
2020 Standout
A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
1997
Interventions for enhancing medication adherence
2014 Standout
Cataracts
2017 Standout
Plasma tau in Alzheimer disease
2016 StandoutNobel
The Metabolic Syndrome
2008 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice
2005
Daily usage and efficiency of remote home monitoring in hypertensive patients over a one-year period
2005
Medication Adherence
2009 Standout
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
2003
High Density Lipoproteins and Arteriosclerosis
2001
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
2005
Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice
2004
Decision Making in Health and Medicine: Integrating Evidence and Values
2001
Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data
2006
Conceptualizing a Model
2012
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Antiinflammatory Properties of HDL
2004 Standout
Indication for cataract surgery. Do we have evidence of who will benefit from surgery? A systematic review and meta‐analysis
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Javier Mar being referenced
Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C
2014
An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain
2013
Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias
2009
Geographical variations in the benefit of applying a prioritization system for cataract surgery in different regions of Spain
2008
Unmet needs for cataract surgery in Spain according to indication criteria. Evaluation through a simulation model
2008
Ambulatory Blood Pressure Monitoring and Diagnostic Errors in Hypertension
1998
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea
2003
Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke
2005
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
1996
Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia
2015
Cost‐effectiveness analysis of therapeutic strategies for patients with chronic hepatitis C previously not responding to interferon
2003
Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?
2001
Spanish recommendations on economic evaluation of health technologies
2010
Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
2012
Calculation of Prevalence with Markov Models: Budget Impact Analysis of Thrombolysis for Stroke
2008
Cost-analysis of viscosupplementation treatment with hyaluronic acid in candidate knee replacement patients with osteoarthritis
2013
Modeling Using Discrete Event Simulation
2012
Trends in the incidence of hip fractures in women in the Basque country
2010
Cost-Effectiveness of the Use of Biomarkers in Cerebrospinal Fluid for Alzheimer's Disease
2014